Aquestive Therapeutics, Inc. AQST Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s retained earnings?
- Aquestive Therapeutics, Inc. (AQST) reported retained earnings of -$455.06M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s retained earnings changed year-over-year?
- Aquestive Therapeutics, Inc.'s retained earnings decreased by 17.8% year-over-year, from -$386.14M to -$455.06M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s retained earnings has grown at a 19.1% compound annual growth rate (CAGR), from -$186.26M to -$447M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.